Shikoku Chemicals : Consolidated Financial Results for the Nine Months Ended December 31, 2021

Consolidated Financial Results

for the Nine Months Ended December 31, 2021

[Japanese GAAP]

January 25, 2022

Company name: SHIKOKU CHEMICALS CORPORATION

Stock exchange listing: Tokyo Stock Exchange

Code number: 4099

URL: https://www.shikoku.co.jp/

Representative: Naoto Tanaka, President and C.E.O.

Contact: Yoshinori Manabe, Director, Executive Officer, Head of Business Promotion Division

Phone: [phone]

Scheduled date of filing quarterly securities report: February 14, 2022

Scheduled date of commencing dividend payments: -

Availability of supplementary briefing material on quarterly financial results: Available

Schedule of quarterly financial results briefing session: Not scheduled

(Amounts less than one million yen are rounded down)

1. Consolidated Financial Results for the Nine Months Ended December 31, 2021 (from April 1, 2021 to December 31, 2021)

(1) Consolidated Operating Results				(% indicates changes from the previous corresponding period.)
				Net sales			Operating profit			Ordinary profit	Profit attributable to
								owners of parent
Nine months ended			Million yen	%		Million yen	%				Million yen	%	Million yen	%
December 31, 2021			39,229	8.9					6,158	26.0			6,721		29.1		4,794	22.6
December 31, 2020			36,024	(5.6)					4,888	(12.2)			5,206		(9.6)		3,911	(2.9)
(Note) Comprehensive		income:	Nine months ended December 31, 2021: ¥5,561 million [4.7 %]
					Nine months ended December 31, 2020: ¥5,310 million [13.5 %]
			Basic earnings			Diluted earnings
				per share					per share
Nine months ended						Yen							Yen
December 31, 2021				87.27							-
December 31, 2020				70.05							-
(2) Consolidated Financial Position
				Total assets					Net assets		Equity ratio
							Million yen					Million yen				%
As of December 31, 2021		109,946					79,514				71.5
As of March 31, 2021			107,344					76,566				70.5
(Reference) Equity: As of	December 31, 2021:	¥78,660 million
			As of March 31, 2021: ¥75,718 million
2. Dividends
															Annual dividends
							1st						2nd			3rd		Fiscal year-		Total
							quarter-end		quarter-end			quarter-end		end
									Yen			Yen			Yen			Yen			Yen
Year ended March 31, 2021						-			12.00			-			12.00			24.00
Year ending March 31, 2022						-			12.00				-
Year ending March 31, 2022																		12.00			24.00
(Forecast)
(Note) Revisions to the cash dividends forecasts most recently announced: None

3. Forecast of Consolidated Financial Results for the Year Ending March 31, 2022 (from April 1, 2021 to March 31, 2022)

(% indicates changes from the previous corresponding period.)

		Net sales		Operating profit	Ordinary profit	Profit attributable	Basic earnings
			to owners of parent	per share
Full year	Million yen	%	Million yen	%	Million yen	%	Million yen	%	Yen
53,500	7.9	8,400	13.5	9,000	12.5	6,700	16.3	122.12
(Notes) 1.	Revisions	to the financial results forecast most recently announced: Yes
2.	For the forecast of consolidated financial results, please also refer to the "Notice Concerning Financial
	Results Forecast" announced today (January 25, 2022).

* Notes:

1. Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in changes in scope of consolidation): No
2. Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: Yes
3. Changes in accounting policies, changes in accounting estimates and retrospective restatement
4. 1. Changes in accounting policies due to the revision of accounting standards: Yes
   2. Changes in accounting policies other than 1) above: No
   3. Changes in accounting estimates: No
   4. Retrospective restatement: No
5. Total number of issued shares (ordinary shares)
6. 1. Total number of issued shares at the end of the period (including treasury shares):

December 31, 2021: 54,832,263 shares

March 31, 2021: 55,877,263 shares

1. Total number of treasury shares at the end of the period: December 31, 2021: 205,688 shares
   March 31, 2021: 212,603 shares
2. Average number of shares during the period:

Nine months ended December 31, 2021: 54,936,628 shares

Nine months ended December 31, 2020: 55,842,155 shares

• These quarterly financial results are outside the scope of quarterly review by certified public accountants or audit firms
• Explanation regarding the appropriate use of financial results forecasts and other special items

Forward-looking statements such as operating results forecasts and other projections contained in this report are based on information currently available to the Company and certain assumptions deemed reasonable. Actual results may differ significantly from these forecasts due to a wide range of factors. For the assumptions underlying the operating results forecasts and cautionary notes concerning their use, please refer to "(3) Explanation of Consolidated Financial Results Forecast and Other Forward-looking Information" under "1. Qualitative Information on Quarterly Financial Results for the Period under Review" on page 3 of the attached documents to the quarterly financial statements.

Table of Contents
1. Qualitative Information on Quarterly Financial Results for the Period under Review ...............................	2
(1)	Explanation of Operating Results ............................................................................................................	2
(2)	Explanation of Financial Position ...........................................................................................................	3
(3)	Explanation of Consolidated Financial Results Forecast and Other Forward-looking Information .......	3
2. Quarterly Consolidated Financial Statements and Primary Notes ..............................................................	4
(1)	Quarterly Consolidated Balance Sheets ..................................................................................................	4
(2)	Quarterly Consolidated Statements of Income and Comprehensive Income ..........................................	6
(3)	Notes to Quarterly Consolidated Financial Statements ...........................................................................	8
	(Notes on going concern assumption) .....................................................................................................	8
	(Notes in the case of significant changes in shareholders' equity) ..........................................................	8
	(Accounting policies adopted specially for the preparation of quarterly consolidated financial statements)	.8
	(Changes in accounting policies) ............................................................................................................	8
	(Additional information) .........................................................................................................................	9
	(Segment information, etc.) ...................................................................................................................	10

1

1. Qualitative Information on Quarterly Financial Results for the Period under Review

(1) Explanation of Operating Results

The Japanese economy during the nine months ended December 31, 2021 saw a gradual recovery following progress in vaccination against the novel coronavirus disease (COVID-19) and the lifting of the state of emergency on September 30. However, economic outlook is becoming more uncertain due to growing impact of the spread of the Omicron strain from the end of the year, consumer sentiment worsened by rising prices on the back of high resource prices and the depreciation of the yen, and supply constraints such as semiconductor shortages. Overseas economies continue to pick up globally, but supply constraints and high resource prices are becoming more serious, raising concerns for rising inflation. Therefore, the situation remains unpredictable.

Under these circumstances, for the nine months ended December 31, 2021 (from April 1, 2021 to December 31, 2021), the Group posted net sales of ¥39,229 million (up 8.9% year-on-year), operating profit of ¥6,158 million (up 26.0% year-on-year), ordinary profit of ¥6,721 million (up 29.1% year-on-year) and profit attributable to owners of parent of ¥4,794 million (up 22.6% year-on-year), all of which increased from the previous year's results. In addition, even when compared with periods before the COVID-19 pandemic, net sales, ordinary profit, and profit attributable to owners of parent achieved high levels against the backdrop of global economic recovery, hitting record highs.

Operating results by segment are as follows.

1. Chemicals operations (Inorganic chemicals)
   Sales of insoluble sulfur, a material for radial tires, largely surpassed those of the previous fiscal year, which was affected by the spread of COVID-19, due to solid demand for replacement tires, despite a decline in automobile production resulting from semiconductor shortages. Sales of carbon disulfide for rayon and cellophane, and sodium sulfate for bath agents and detergents increased year on year due to a rebound from the
   COVID-19 pandemic. (Organic chemicals)
   Regarding chlorinated isocyanuric acid for disinfectants, the domestic market performed better than the previous year mainly due to a recovery in sales of agents for swimming pools following the partial resumption of swimming lessons at schools. In the U.S. market, the balance between supply and demand is tightening mainly due to a recovery in economic conditions and stay-at-home demand, and the Company tried to improve profitability by passing on soaring resource prices and distribution costs, which resulted in a significant increase
   in profitability. (Fine chemicals)
   Regarding Glicoat-SMD, a heat-resistant soluble OSP (Organic Solderability Preservative) for printed wiring boards, sales remained solid, against a backdrop of the growth of electronics markets worldwide. Sales of advanced & specialty chemicals such as epoxy resin curing agent (imidazoles), resin modifier (glycoluril derivatives, etc.) and semiconductor processing materials increased year on year, backed by a recovery in demand for use in electronic components and automobiles.

As a result, net sales for the chemicals operations segment were ¥25,499 million (up 16.0% year-on-year), and segment profit was ¥5,734 million (up 47.3% year-on-year), both surpassing the previous year's results.

2) Housing Materials operations

Although the number of new housing starts showed signs of a slight recovery, sales of interior, exterior finishes and paving materials and exterior products remained sluggish, as governments and private companies deferred or had a wait-and-see attitude for their projects or capital investment, against a backdrop of falling consumer sentiment and uncertainty about the future. Profitability also declined due to soaring prices of raw materials including aluminum ingots.

As a result, net sales for the housing materials operations segment were ¥12,772 million (down 4.4% year-

2

on-year), and segment profit was ¥1,693 million (down 25.0% year-on-year), both falling below the previous year's results.

Reference information

[Overseas net sales]

	Nine months ended December 31, 2020	Nine months ended December 31, 2021
	(from April 1, 2020 to December 31, 2020)	(from April 1, 2021 to December 31, 2021)
	Net sales	Overseas net sales to	Net sales	Overseas net sales to
	(Million yen)	consolidated net sales (%)	(Million yen)	consolidated net sales (%)
Asia	5,103	14.1	6,348	16.2
North America	4,496	12.5	5,587	14.2
Other regions	1,405	3.9	1,560	4.0
Total	11,004	30.5	13,495	34.4
Consolidated net	36,024		39,229
sales

1. Explanation of Financial Position (Status of assets, liabilities and net assets)
   Total assets increased by ¥2,602 million from the end of the previous fiscal year to ¥109,946 million. Major increases were ¥2,094 million in investment securities and ¥860 million in notes and accounts receivable - trade, and a major decrease was ¥2,550 million in cash and deposits.
   Liabilities decreased by ¥346 million from the end of the previous fiscal year to ¥30,431 million. Major decreases were ¥1,537 million in retirement benefit liability and ¥565 million in income taxes payable.
   Net assets increased by ¥2,948 million from the end of the previous fiscal year to ¥79,514 million. Major increases were ¥2,184 million in retained earnings and ¥685 million in valuation difference on available-for-sale securities.
   As a result, equity ratio rose to 71.5%, from 70.5% at the end of the previous fiscal year.
2. Explanation of Consolidated Financial Results Forecast and Other Forward-looking Information

The full-year financial results forecast has been revised from the initial plan (announced on April 27, 2021). Economic activities picked up during the nine months ended December 31, 2021 following progress in vaccination against COVID-19 and the lifting of the state of emergency on September 30. Although the situation looks to remain unpredictable due to the spread of the Omicron strain from the end of the year and other factors, full-year financial results are now expected to exceed the previously announced forecast, in light of continuing strong sales of chlorinated isocyanuric acid in the U.S. market and improvement in profitability of the chemicals

operations due to a depreciation of the yen exchange rate.

Net sales, operating profit, ordinary profit, profit attributable to owners of parent, and basic earnings per share are all forecast to reach new highs.

Assumptions for the average exchange rates for the full year are ¥111 to U.S. dollar and ¥130 to Euro.

For details, please also refer to the "Notice Concerning Financial Results Forecast" announced today (January 25, 2022).

3